You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / NGL FINECHEM

NGL FINECHEM
Intrinsic Value | Fundamental Analysis

Returns | 1W : 8.7% , 1M : 66%,1Y : 713.6%
BOM : 524774     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Jul 29,2021
Price(EOD): Rs. 3,369.45
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
NGL FINECHEM 8.7% 66% 713.6%
SUN PHARMACEUTICAL INDUSTRIES 1.3% 3.8% 44.6%
DR REDDYS LABORATORIES -13.9% -14% 17.8%
DIVIS LABORATORIES 0.5% 11.2% 107.1%
CIPLA -6.9% -9.9% 36.4%
BIOCON -4% -6.2% -4.5%
AUROBINDO PHARMA -5.8% -6.2% 17.5%
LUPIN -8.1% -6.5% 30.6%
TORRENT PHARMACEUTICALS -0.2% 4% 34.1%


FUNDAMENTAL ANALYSIS OF NGL FINECHEM

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than NGL FINECHEM Plus/Pro


VALUATION OF NGL FINECHEM

 
Valuation Score
[As on : Jul 29,2021 ]

Ratio Standalone
P/E
P/B
P/S
196.35
P/E Calculated based on EPS of 17.16
[ Mar2020 - Standalone Results ]

20.57
P/B Calculated based on Book Value of 163.81
[ Mar2020 - Standalone Results ]

8.19
P/S Calculated based on Revenues of 255.208 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than NGL FINECHEM Plus/Pro


FAIR VALUE OF NGL FINECHEM

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
695%
291%
329%

SHARE PRICE MOMENTUM OF NGL FINECHEM

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.28
0.29
0.37
0.31
0.29
0.29
-
0.19
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Jun2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-1.37%
-4.54%
-8.83%
-18.29%
102.33%
840.38%
3103.63%
9767.59%
QtrlyTrend
0
Latest Qtr: Mar2021

NGL FINECHEM related INDICES

No BSE index found!
No NSE index found

FAQ [Frequently Asked Questions]


Is NGL FINECHEM good for long term investment?

As on 29-Jul-2021, the Fundamentals of NGL FINECHEM look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of NGL FINECHEM . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is NGL FINECHEM UnderValued or OverValued?

As on 29-Jul-2021, NGL FINECHEM is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of NGL FINECHEM ?

As on 29-Jul-2021, the Intrinsic Value of NGL FINECHEM is Rs. 785.02 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 423.86
Fair Value [Median EV / Sales Model] : Rs. 861.74
Fair Value [Median Price / Sales Model] : Rs. 785.02
Median Fair Value of NGL FINECHEM : Rs. 785.02

Is NGL FINECHEM trading at a Premium or Discount?

As on 29-Jul-2021, NGL FINECHEM is trading at a Premium of 329% based on the estimates of Median Intrinsic Value!

What is the Financial Performance of Industry Peers of NGL FINECHEM ?

Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of BIOCON LTD | BOM: 532523 | NSE: BIOCON
Share Price & Financials of AUROBINDO PHARMA LTD | BOM: 524804 | NSE: AUROPHARMA
Share Price & Financials of LUPIN LTD | BOM: 500257 | NSE: LUPIN
Share Price & Financials of TORRENT PHARMACEUTICALS LTD | BOM: 500420 | NSE: TORNTPHARM
Share Price & Financials of CADILA HEALTHCARE LTD | BOM: 532321 | NSE: CADILAHC
Share Price & Financials of ABBOTT INDIA LTD | BOM: 500488 | NSE: ABBOTINDIA
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of BIOCON LTD
Quarterly Results of AUROBINDO PHARMA LTD
Quarterly Results of LUPIN LTD
Quarterly Results of TORRENT PHARMACEUTICALS LTD
Quarterly Results of CADILA HEALTHCARE LTD
Quarterly Results of ABBOTT INDIA LTD

What are the Frequent Comparisons with NGL FINECHEM ?

Compare Analytics
NGL FINECHEM LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
NGL FINECHEM LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
NGL FINECHEM LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
NGL FINECHEM LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
NGL FINECHEM LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
NGL FINECHEM LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
NGL FINECHEM LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
NGL FINECHEM LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
NGL FINECHEM LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of BIOCON LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of LUPIN LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of ABBOTT INDIA LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z